Modulation of Brain Tumor Capillaries for Enhanced Drug Delivery Selectively to Brain Tumor

May 22, 2004Cancer control : journal of the Moffitt Cancer Center

Changing brain tumor blood vessels to improve drug delivery specifically to brain tumors

AI simplified

mRNA Technology on OpenScience ↗PubMed ↗DOI ↗

Abstract

Brain tumor capillary endothelial cells overexpress unique protein markers not found in normal cells.

These unique protein markers may facilitate targeted drug delivery to brain tumors.
Biochemical modulation of these markers has been shown to enhance drug delivery selectively to tumors in rat models.
The increase in blood-tumor barrier permeability is associated with accelerated formation of small vesicles that transport therapeutic molecules.
Other existing drug delivery methods have significant drawbacks compared to this targeted approach.

AI simplified

BACKGROUND: The blood-brain tumor barrier (BTB) significantly impedes delivery of most hydrophilic molecules to brain tumors. Several promising strategies, however, have been developed to overcome this problem.

METHODS: We discuss several drug delivery methods to brain tumor, including intracerebroventricular, convection enhanced delivery, BBB/BTB disruption, and BTB permeability modulation, which was developed in our laboratory.

RESULTS: Using immunolocalization, immunoblotting, and potentiometric studies, we found that brain tumor capillary endothelial cells overexpress certain unique protein markers that are absent or barely detectable in normal capillary endothelial cells. We biochemically modulated these markers to sustain and enhance drug delivery, including molecules of varying sizes, selectively to tumors in rat syngeneic and xenograft brain tumor models. We also demonstrated that the cellular mechanism for vasomodulator-mediated BTB permeability increase is due to accelerated formation of pinocytotic vesicles that transport therapeutic molecules across the BTB.

CONCLUSIONS: Other methods to deliver drugs across the BTB are effective but have severe drawbacks. Our strategy targets BTB-specific proteins to increase antineoplastic drug delivery selectively to brain tumors with few or no side effects, thus increasing the possibility of improving brain tumor treatment.

Full Text

Full text is available at the source.

View full text (PDF) ↗View full text ↗

Modulation of Brain Tumor Capillaries for Enhanced Drug Delivery Selectively to Brain Tumor

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the mrna technology brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the mrna technology brief